Growth Metrics

HCA Healthcare (HCA) Common Equity (2016 - 2025)

HCA Healthcare (HCA) has disclosed Common Equity for 16 consecutive years, with -$6.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity fell 1185.95% to -$6.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.0 billion, a 1185.95% decrease, with the full-year FY2025 number at -$6.0 billion, down 1185.95% from a year prior.
  • Common Equity was -$6.0 billion for Q4 2025 at HCA Healthcare, down from -$2.2 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $2.5 billion in Q1 2021 to a low of -$6.0 billion in Q4 2025.
  • A 5-year average of $110.2 million and a median of $437.5 million in 2022 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 1552.05% in 2023, then crashed 1185.95% in 2025.
  • HCA Healthcare's Common Equity stood at $1.5 billion in 2021, then plummeted by 104.9% to -$73.0 million in 2022, then soared by 1552.05% to $1.1 billion in 2023, then crashed by 47.64% to $555.0 million in 2024, then plummeted by 1185.95% to -$6.0 billion in 2025.
  • Per Business Quant, the three most recent readings for HCA's Common Equity are -$6.0 billion (Q4 2025), -$2.2 billion (Q3 2025), and -$1.2 billion (Q2 2025).